Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Submitted by
admin
on April 19, 2017 - 4:12pm
Source:
Fierce Pharma
News Tags:
FDA
AstraZeneca
ZS-9
ZS Pharma
hyperkalemia
Headline:
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Do Not Allow Advertisers to Use My Personal information
